Cancer Research UK logo.
SearchDonate
  • Search

A trial of cediranib for alveolar soft part sarcoma (CASPS)

Overview

Cancer types:

Sarcoma, Secondary cancers, Soft tissue sarcoma

Status:

Results

Phase:

Phase 2

Details

This trial looked cediranib to treat alveolar soft part sarcoma that had spread.

The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2016. The team published the results in 2019.

Recruitment start: 11 May 2011

Recruitment end: 31 July 2016

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Ian Judson

Supported by

AstraZeneca

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Institute of Cancer Research (ICR)

NIHR Clinical Research Network: Cancer

The Royal Marsden NHS Foundation Trust

Other information

This is Cancer Research UK trial number CRUK/10/021.

Last reviewed: 02 Sept 2025

CRUK internal database number: 6173

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.